CBN launches FX price verification system portal
The Central Bank of Nigeria (CBN) has launched a new portal called the Foreign Exchange (FX) Price Verification System (PVS),
Read More
MARKETS
Court restrains FBN Holdings from organising AGM on Tuesday
The Federal High Court sitting in Lagos has granted an interim order restraining FBN Holdings Plc from holding its
Read More
NGX, CIS, ASHON to work with MOFI on market development, listings
Nigerian Exchange Limited (NGX), along with the Chartered Institute of Stockbrokers (CIS) and the Association of Securities Dealing Houses
Read More
CBN explains reason behind Naira crash
The Central Bank of Nigeria (CBN), has attributed the crash of the naira against the dollar and its inability
Read More
More companies’ should integrate ESG into their overall business strategy – Awe
The Chief Executive Officer, NGX Regulation Limited (NGX, Ms Tinuade Awe, has urged companies to incorporate Environmental, Social, and Governance
Read More
First Bank allays fears of staff retrenchment over introduction of robotics
The Managing Director and Chief Executive Officer of the First Bank of Nigeria, Mr Adesola Adeduntan, has said that
Read More
Seplat majority shareholders uphold sanctity of half-year results
dismiss ISAN allegations express confidence in management A group consisting of shareholders with major stake in Nigeria’s indigenous oil
Read More
SEC, PENCOM, NGX reiterate commitment to deepening securities lending
calls for more collaboration, awareness With the aim of enhancing investor participation and securities lending transactions in the Nigerian
Read More
DMO offers FGN Bonds for subscription with interest rates up to 10.634% per annum
The Debt Management Office (DMO) has opened offers for subscription for two-year and three years tenure of
Read More
Nigerian shareholders demand fair compensation, as GSK closes operations in Nigeria
Nigerian shareholders have demanded fair compensation for their investment, as the Nigerian subsidiary of the British pharmaceutical company, GlaxoSmithKline Consumer
Read More